Analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a research report issued on Wednesday. The firm set a “hold” rating on the stock.
Retractable Technologies Price Performance
Shares of NYSE RVP opened at $1.05 on Wednesday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.41 and a current ratio of 8.28. The company has a market cap of $31.44 million, a PE ratio of -4.38 and a beta of 2.11. The business has a 50-day simple moving average of $1.20 and a two-hundred day simple moving average of $1.16. Retractable Technologies has a fifty-two week low of $0.95 and a fifty-two week high of $1.88.
Institutional Investors Weigh In On Retractable Technologies
A number of institutional investors and hedge funds have recently modified their holdings of RVP. Jane Street Group LLC purchased a new position in Retractable Technologies during the fourth quarter valued at approximately $27,000. Cubist Systematic Strategies LLC acquired a new position in Retractable Technologies during the second quarter worth $40,000. Dimensional Fund Advisors LP acquired a new position in shares of Retractable Technologies in the 3rd quarter valued at $52,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main acquired a new position in shares of Retractable Technologies in the 2nd quarter valued at $54,000. Finally, Virtu Financial LLC purchased a new stake in shares of Retractable Technologies in the 2nd quarter valued at $57,000. Institutional investors and hedge funds own 7.58% of the company’s stock.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
See Also
- Five stocks we like better than Retractable Technologies
- ETF Screener: Uses and Step-by-Step Guide
- Comprehensive PepsiCo Stock Analysis
- Quiet Period Expirations Explained
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What is MarketRankā¢? How to Use it
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.